Administration of OKT3 as a two-hour infusion attenuates first-dose side effects. [electronic resource]
Producer: 19980112Description: 1620-3 p. digitalISSN:- 0041-1337
- Anaphylatoxins -- metabolism
- Animals
- Complement Activation -- drug effects
- Complement C3a -- analogs & derivatives
- Drug Administration Schedule
- Dyspnea -- chemically induced
- Infusions, Intravenous
- Kidney Transplantation -- adverse effects
- Mice
- Muromonab-CD3 -- administration & dosage
- Neutrophil Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.